GeneOne Life Science, Inc.
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
011000 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시
- Website:
- https://www.genels.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GeneOne Life Science, Inc. is a biotechnology research and development company specializing in nucleic acid-based biomedicines. The company focuses on developing DNA and mRNA vaccines to combat emerging infectious diseases, nucleic acid therapeutics such as plasmid-encoded monoclonal antibodies (Plas-mAbs®) and recombinant proteins for conditions like cancer and autoimmune disorders, and immunomodulatory small molecule drugs. Its core technologies include a DNA plasmid delivery platform designed as a potential alternative to viral vectors. Leveraging its subsidiary, VGXI, GeneOne has capabilities for large-scale cGMP manufacturing of its gene-based medicines to support global health initiatives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.6 KB | ||
| 2025-09-08 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 15.9 KB | ||
| 2025-09-04 00:00 |
Share Issue/Capital Change
소액공모실적보고서
|
Korean | 25.7 KB | ||
| 2025-09-04 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 7.5 KB | ||
| 2025-09-03 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 7.1 KB | ||
| 2025-08-29 00:00 |
Prospectus
소액공모공시서류(지분증권)
|
Korean | 1.9 MB | ||
| 2025-08-29 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 49.7 KB | ||
| 2025-08-29 00:00 |
Share Issue/Capital Change
유상증자신주발행가액(안내공시)
|
Korean | 4.2 KB | ||
| 2025-08-22 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 36.6 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 102.7 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 34.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.9 MB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.3 MB | ||
| 2025-08-12 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 29.1 KB |
Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
